Icatibant Subcutaneous and Mesalamine Controlled-Release Capsules
Determining the interaction of Icatibant Subcutaneous and Mesalamine Controlled-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: icatibant
Brand name: Firazyr
Synonyms: Icatibant
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Icatibant Subcutaneous-Mesalamine Delayed Release Tablets
- Icatibant Subcutaneous-Mesalamine Long-Acting Capsules (Apriso)
- Icatibant Subcutaneous-Mesalamine Long-Acting Capsules (Delzicol)
- Icatibant Subcutaneous-Mesalamine Long-Acting Capsules (Pentasa)
- Icatibant Subcutaneous-Mesalamine rectal
- Icatibant Subcutaneous-Mesalamine Rectal Enema
- Mesalamine Controlled-Release Capsules-ICG for Injection Set
- Mesalamine Controlled-Release Capsules-Iclevia
- Mesalamine Controlled-Release Capsules-Iclusig
- Mesalamine Controlled-Release Capsules-Icosapent
- Mesalamine Controlled-Release Capsules-Icosapent ethyl
- Mesalamine Controlled-Release Capsules-Icosapent Ethyl Capsules